CU20140088A7 - Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina - Google Patents
Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropinaInfo
- Publication number
- CU20140088A7 CU20140088A7 CU2014000088A CU20140088A CU20140088A7 CU 20140088 A7 CU20140088 A7 CU 20140088A7 CU 2014000088 A CU2014000088 A CU 2014000088A CU 20140088 A CU20140088 A CU 20140088A CU 20140088 A7 CU20140088 A7 CU 20140088A7
- Authority
- CU
- Cuba
- Prior art keywords
- spiroindoline
- antagonists
- derivatives
- diseases
- prophylaxis
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 abstract 2
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 abstract 2
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 abstract 2
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000003200 Adenoma Diseases 0.000 abstract 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 206010020112 Hirsutism Diseases 0.000 abstract 1
- 206010062767 Hypophysitis Diseases 0.000 abstract 1
- 206010061535 Ovarian neoplasm Diseases 0.000 abstract 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004720 fertilization Effects 0.000 abstract 1
- 230000002710 gonadal effect Effects 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 201000010260 leiomyoma Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001817 pituitary effect Effects 0.000 abstract 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 abstract 1
- 208000006155 precocious puberty Diseases 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 201000002859 sleep apnea Diseases 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Derivados de espiroindolina, procesos para su preparación y composiciones farmaceúticas con los mismos, su uso para el tratamiento y/o profilaxis de enfermedades y su uso en la elaboración de medicamentos para el tratamiento y /o profilaxis de enfermedades, en especial enfermedades relacionadas con las hormonas sexuales, tanto en hombres como en mujeres, en particular aquellas seleccionadas del grupo de endometriosis, fibroides uterina, enfermedad de ovario poliquístico, hirsutismo, pubertad precoz, neoplasis dependientes de esteroides gonadales tales como cánceres de próstata, de mama y de ovario, adenomas pituitarios gonodotrópicos, apnea del sueño, síndrome de intestino irritable, síndrome premenstrual, hipertrofia prostática benigna, anticoncepción y esterilidad ( por ejemplo, terapia de reproducción asistida tal como la fertilización in vitro). La presente solicitud se relaciona en particular con derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina ( GnRH).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12151291 | 2012-01-16 | ||
| PCT/EP2013/050676 WO2013107743A1 (en) | 2012-01-16 | 2013-01-15 | Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20140088A7 true CU20140088A7 (es) | 2014-12-26 |
Family
ID=47559493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2014000088A CU20140088A7 (es) | 2012-01-16 | 2014-07-16 | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20140357655A1 (es) |
| EP (1) | EP2804867A1 (es) |
| JP (1) | JP2015503607A (es) |
| KR (1) | KR20140112075A (es) |
| CN (1) | CN104169287A (es) |
| AP (1) | AP2014007738A0 (es) |
| AU (1) | AU2013211091A1 (es) |
| BR (1) | BR112014017483A8 (es) |
| CA (1) | CA2860986A1 (es) |
| CL (1) | CL2014001871A1 (es) |
| CO (1) | CO7010832A2 (es) |
| CR (1) | CR20140343A (es) |
| CU (1) | CU20140088A7 (es) |
| DO (1) | DOP2014000167A (es) |
| EA (1) | EA201491344A1 (es) |
| GT (1) | GT201400153A (es) |
| HK (1) | HK1199878A1 (es) |
| IL (1) | IL233485A0 (es) |
| MA (1) | MA35867B1 (es) |
| MX (1) | MX2014008630A (es) |
| PE (1) | PE20141699A1 (es) |
| PH (1) | PH12014501616A1 (es) |
| SG (1) | SG11201403749VA (es) |
| TN (1) | TN2014000306A1 (es) |
| WO (1) | WO2013107743A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR095785A1 (es) * | 2013-04-09 | 2015-11-11 | Bayer Pharma AG | Derivados de espiroindolina y composiciones farmacéutica de los mismos |
| WO2015007606A1 (en) * | 2013-07-15 | 2015-01-22 | Bayer Pharma Aktiengesellschaft | Spiroindoline derivatives and pharmaceutical compositions thereof |
| WO2015082374A1 (en) * | 2013-12-05 | 2015-06-11 | Bayer Pharma Aktiengesellschaft | Spiroindoline-thiopyran-imine-oxide derivatives as gonadotropin-releasing hormone receptor antagonists and pharmaceutical compositions thereof |
| EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
| WO2015091315A1 (en) * | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Spiro[indolin-3,4'-piperidine] derivatives as gnrh receptor antagonists |
| EP3339846B1 (en) * | 2016-12-22 | 2020-12-09 | Malvern Panalytical B.V. | Method of measuring properties of a thin film stack |
| SG11201911598WA (en) | 2017-06-05 | 2020-01-30 | ObsEva SA | Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis |
| CN107840851A (zh) * | 2017-12-21 | 2018-03-27 | 扬州大学 | 吲哚螺吡咯嗪化合物及其合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849780A (en) * | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
| TW200522944A (en) * | 2003-12-23 | 2005-07-16 | Lilly Co Eli | CB1 modulator compounds |
-
2013
- 2013-01-15 EA EA201491344A patent/EA201491344A1/ru unknown
- 2013-01-15 KR KR1020147022494A patent/KR20140112075A/ko not_active Withdrawn
- 2013-01-15 SG SG11201403749VA patent/SG11201403749VA/en unknown
- 2013-01-15 PE PE2014001114A patent/PE20141699A1/es not_active Application Discontinuation
- 2013-01-15 BR BR112014017483A patent/BR112014017483A8/pt not_active Application Discontinuation
- 2013-01-15 CN CN201380014647.3A patent/CN104169287A/zh active Pending
- 2013-01-15 AP AP2014007738A patent/AP2014007738A0/xx unknown
- 2013-01-15 AU AU2013211091A patent/AU2013211091A1/en not_active Abandoned
- 2013-01-15 CA CA2860986A patent/CA2860986A1/en not_active Abandoned
- 2013-01-15 MX MX2014008630A patent/MX2014008630A/es unknown
- 2013-01-15 WO PCT/EP2013/050676 patent/WO2013107743A1/en not_active Ceased
- 2013-01-15 US US14/371,312 patent/US20140357655A1/en not_active Abandoned
- 2013-01-15 EP EP13700304.2A patent/EP2804867A1/en not_active Withdrawn
- 2013-01-15 HK HK15100323.1A patent/HK1199878A1/xx unknown
- 2013-01-15 JP JP2014551648A patent/JP2015503607A/ja active Pending
-
2014
- 2014-07-02 IL IL233485A patent/IL233485A0/en unknown
- 2014-07-11 PH PH12014501616A patent/PH12014501616A1/en unknown
- 2014-07-15 CL CL2014001871A patent/CL2014001871A1/es unknown
- 2014-07-15 TN TNP2014000306A patent/TN2014000306A1/fr unknown
- 2014-07-15 MA MA37214A patent/MA35867B1/fr unknown
- 2014-07-16 CO CO14154059A patent/CO7010832A2/es not_active Application Discontinuation
- 2014-07-16 CU CU2014000088A patent/CU20140088A7/es unknown
- 2014-07-16 GT GT201400153A patent/GT201400153A/es unknown
- 2014-07-16 CR CR20140343A patent/CR20140343A/es unknown
- 2014-07-16 DO DO2014000167A patent/DOP2014000167A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2014001871A1 (es) | 2014-11-03 |
| TN2014000306A1 (en) | 2015-12-21 |
| HK1199878A1 (en) | 2015-07-24 |
| WO2013107743A1 (en) | 2013-07-25 |
| BR112014017483A2 (pt) | 2017-06-13 |
| MA35867B1 (fr) | 2014-12-01 |
| GT201400153A (es) | 2015-05-22 |
| AP2014007738A0 (en) | 2014-07-31 |
| US20140357655A1 (en) | 2014-12-04 |
| JP2015503607A (ja) | 2015-02-02 |
| CA2860986A1 (en) | 2013-07-25 |
| IL233485A0 (en) | 2014-08-31 |
| PH12014501616A1 (en) | 2014-10-13 |
| KR20140112075A (ko) | 2014-09-22 |
| CN104169287A (zh) | 2014-11-26 |
| CO7010832A2 (es) | 2014-07-31 |
| DOP2014000167A (es) | 2014-08-31 |
| SG11201403749VA (en) | 2014-07-30 |
| AU2013211091A1 (en) | 2014-08-07 |
| EP2804867A1 (en) | 2014-11-26 |
| BR112014017483A8 (pt) | 2017-07-04 |
| CR20140343A (es) | 2014-09-08 |
| PE20141699A1 (es) | 2014-11-29 |
| EA201491344A1 (ru) | 2015-04-30 |
| MX2014008630A (es) | 2014-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20140088A7 (es) | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina | |
| IN2012DN05082A (es) | ||
| CL2015002098A1 (es) | “compuestos derivados de benzotiofeno, antagonistas de receptores de estrógenos y degradantes selectivos de éstos (sreds); composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer de mamas, ovarios, endometrial, próstata, uterino, cervical y pulmones”. pct | |
| CL2015001508A1 (es) | Compuestos derivados de bencimidazol, antagonistas de receptores ep4; composicion farmaceutica; combinacion farmaceutica; uso para tratar y/o prevenir enfermedades tales como endometriosis, hemorragias uterinas, dismenorrea, canceres de pulmon, de intestino, de mama, de prostata, entre otros. | |
| MX368844B (es) | Derivados de imidazolina, métodos de preparación de los mismos, y sus aplicaciones en medicina. | |
| CU20130163A7 (es) | El anticuerpo neutralizador del receptor de prolactina mat3 y su uso terapéutico | |
| MX387228B (es) | Compuestos de pirazol como moduladores del receptor de hormona estimuladora de foliculo y sus usos. | |
| ECSP12011616A (es) | Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-arilo, procedimientos para su preparación y su uso para el tratamiento de enfermedades | |
| MX2012003208A (es) | Agonistas de receptores de oxitocina. | |
| MX364985B (es) | Antagonistas de imidazolil progesterona. | |
| BR112014021331A8 (pt) | Antagonistas do receptor do hormônio liberador de gonadotropina, composição farmacêutica compreendendo os mesmos e uso desses | |
| AR079688A1 (es) | Derivados de piridinona y composiciones farmaceuticas de los mismos | |
| ECSP12012226A (es) | Composiciones y métodos para la administración no tóxica de antiprogestinas | |
| CU20150141A7 (es) | Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina | |
| AR096905A1 (es) | Derivados de espiroindolina y composiciones farmacéuticas de los mismos | |
| SV2011003817A (es) | Derivados de estratrieno que comprenden bioisosteros heterociclicos para el anillo fenolico a | |
| CU20110018A7 (es) | Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a |